Overexpression of kallikrein 10 in epithelial ovarian carcinomas

Gynecologic Oncology

Volumn 90, Issue 1, 2003, Pages 44-50

  Shvartsman, Hyun S ^a   Lu, Karen H ^a   Lee, John ^b   Lillie, Jim ^b   Deavers, Michael T ^a   Clifford, Stephanie ^a   Wolf, Judith K ^a   Mills, Gordon B ^a   Bast Jr , Robert C ^a   Gershenson, David M ^a   Schmandt, Rosemarie ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Millenium Predictive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; KALLIKREIN 10; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; TUMOR MARKER; UNCLASSIFIED DRUG; KLK10 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL IMMORTALIZATION; CELL LYSATE; CONTROLLED STUDY; DISEASE MARKER; ENZYME RELEASE; EPITHELIUM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; METASTASIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PERITONEUM CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DNA MICROARRAY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; OVARY TUMOR; PATHOLOGY;

BLOTTING, NORTHERN; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION; KALLIKREINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037824482     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00257-9     Document Type: Article

References (35)

1. Holschneider C.H., Berek J.S. Ovarian cancer epidemiology, biology, and prognostic factors . Semin Surg Oncol. 19:2000;3-10.
2. Marsden D.E., Friedlander M., Hacker N.F. Current management of epithelial ovarian carcinoma a review . Semin Surg Oncol. 19:2000;11-19.
3. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat Genet. S21:1999;10-14.
4. Onyango P. Genomics and cancer. Curr Opin Oncol. 4:2002;79-85.
5. Lakhani S.R., Ashworth A. Microarray and histopathological analysis of tumors the future and the past? Nature Rev Cancer. 1:2001;151-157.
6. Smith D.I. Transcriptional profiling develops molecular signatures for ovarian tumors. Cytometry. 47:2002;60-62.
7. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., Kern S.G., Behling C.A., Monk B.J., Lockhart D.J., Burger R.A., Hampton G.M. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA. 8:2001;1176-1181.
8. Mills G.B., Bast R.C., Srivastava S. Future for ovarian cancer screening novel markers from emerging technologies of transcriptional profiling and proteomics . J Natl Cancer Inst. 93:2001;1437-1439.
9. Ono K., Tanaka T., Tsunoda T., Kitahara O., Kihara C., Okamoto A., Ochiai K., Takagi T., Nakamura Y. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60:2000;5007-5011.
10. Wang K., Gan L., Jeffery E., Gayle M., Gown A.M., Skelly M., Nelson P.S., Ng W.V., Schummer M., Hood L., Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene. 229:1999;101-108.
11. Stephan C., Jung K., Diamandis E.P., Rittenhouse H.G., Lein M., Loening S.A. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. Urology. 59:2002;2-8.
12. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family structure, function, and association to disease . Endocrinol Rev. 22:2001;184-204.
13. Diamandis E.P., Yousef G.M., Luo L., Magklara A., Obiezu C.V. The new human kallikrein gene family implications in carcinogenesis . Trends Endocrinol Metab. 11:2000;54-60.
14. Liu X., Wazer D.E., Wataanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56:1996;3371-3379.
15. Goyal J., Smith K.M., Cowan J.M., Wazer D.E., Lee S.W., Band V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58:1998;4782-4786.
16. Dhar S., Bhargava R., Yunes M., Li B., Goyal J., Naber S.P., Wazer D.E., Band V. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res. 7:2001;3393-3398.
17. Luo L.Y., Grass L., Howarth D.J., Thibault P., Ong H., Diamandis E.P. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin Chem. 47:2001;237-246.
18. Luo L.Y., Grass L., Diamandis E.P. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in breast carcinoma cell line BT-474. Anticancer Res. 20:2000;981-986.
19. Luo L.Y., Bunting P., Scorilas A., Diamandis E.P. Human kallikrein 10 a novel tumor marker for ovarian carcinoma? Clin Chim Acta. 306:2001;111-118.
20. Luo L.Y., Katsaros D., Scorilas A., Fracchioli S., Piccinno R., Rigault de la Longrais I.A., Howarth D.J., Diamandis E.P. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin Cancer Res. 7:2001;2372-2379.
21. Eva A., Robbins K.C., Andersen P.R., Srinivasan A., Tronick S.R., Reddy E.P., Ellmore N.W., Galen A.T., Lautenberger J.A., Papas T.S., Westin E.H., Wong-Staal F., Gallo R.C., Aaronson S.A. Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature. 295:1982;116-119.
22. Siemens C.H., Auersperg N.J. Serial propagation of human ovarian surface epithelium in tissue culture. Cell Physiol. 134:1988;347-356.
23. Kruk P.A., Maines-Bandiera S.L., Auersperg N. A simplified method to culture human ovarian surface epithelium. Lab Invest. 63:1990;132-136.
24. Auesperg N., Maines-Bandiera S.L., Dyck H.G., Druk P.A. Characterization of cultured human ovarian surface epithelial cells phenotypic plasticity and premalignant changes . Lab Invest. 71:1994;510-518.
25. Maines-Bandiera, S.L., Kruk P.A., Auersperg N. Simian virus 40 transformed human ovarian epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol. 167:1992;729-735.
26. Obiezu C.V., Scorilas A., Katsaros D., Massobrio M., Yousef G.M., Fracchioli S., Rigault de la Longrais I.A., Arisio R., Diamandis E.P. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res. 7:2001;2380-2386.
27. Kim H., Scorilas A., Katsaros D., Yousef G.M., Massobrio M., Fracchioli S., Piccinno R., Gordini G., Diamandis E.P. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer. 84:2001;643-650.
28. Diamandis E.P., Yousef G.M., Soosaipillai A.R., Bunting P. Human kallikrein 6 (zyme/protease M/neurosin) a new serum biomarker of ovarian carcinoma . Clin Biochem. 33:2000;579-583.
29. Magklara A., Scorilas A., Katsaros D., Massobrio M., Yousef G.M., Fracchioli S., Danese S., Diamandis E.P. The human KLK8 (neuropsin/ovasin) gene identification of two novel splice variants and its prognostic value in ovarian cancer . Clin Cancer Res. 7:2001;806-811.
30. Yousef G.M., Kyriakopoulou L.G., Scorilas A., Fracchioli S., Ghiringhello B., Zarghooni M., Chang A., Diamandis M., Giardina G., Hartwick W.J., Richiardi G., Massobrio M., Diamandis E.P., Katsaros D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer a new independent and favorable prognostic marker . Cancer Res. 61:2001;7811-7818.
31. Diamandis E.P., Okui A., Mitsui S., Luo L.Y., Soosaipillai A., Grass L., Nakamura T., Howarth D.J., Yamaguchi N. Human kallikrein 11 A new biomarker of prostate and ovarian carcinoma . Cancer Res. 62:2002;295-300.
32. Yousef G.M., Magklara A., Chang A., Jung K., Katsaros D., Diamandis E.P. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61:2001;3425-3431.
33. Auersperg N., Wong A.S.T., Choi K., Kang S.K., Leung, P.C.K. Ovarian surface epithelium biology, endocrinology, and pathology . Endoc Rev. 22:2001;255-288.
34. van Niekerck C.C., Boerman O.C., Ramaekers F.C.S., Poels L.G. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. Am J Pathol. 138:1991;455-463.
35. Czernobilsky B. Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary. Eur J Cell Biol. 37:1985;175-190.